The use case: how Novo Nordisk deploys Celonis
Novo built a digital twin of its clinical trials application process in Celonis and uses it to power a fleet of AI agents that automate regulated clinical development workflows. It also uses Celonis to diagnose whether problems stem from people, process or technology, and to validate KPIs for new software implementations.
More reported results
Figures published in Celonis’s case study. They are not independently measured by usedby.
The team is now orchestrating a fleet of 100+ Celonis-powered AI agents
In the customer’s words
Without Process Intelligence, Enterprise AI at scale is hopeful thinking.Other AI tools used by Novo Nordisk
Other public relationships recorded on usedby.
Explore Novo Nordisk’s AI stack
Celonis users in Biotech & Pharma
Companies in the same sector, with public evidence.
See all Celonis customers
Go straight to the source
Based on Celonis’s published case study. We check the public evidence; the results are reported by the vendor.
celonis.com- Last checked
- Nov 4, 2026
Open source capture What the story claims, and what we checked
What we compared with the page.
- The figure: 12 monthsChecked
The figure is on the page; its label is our wording.
- The passage quoted aboveChecked
Copied word for word from the page, near the name of Novo Nordisk.
- Novo Nordisk uses CelonisChecked
Confirmed line.
- The result itselfNot checked
We quote it; we did not measure it.
The digital twin provided the granular clarity Novo was missing. Bova’s team can now understand overall cycle times and dive into the hidden variables that drive trial success.